Literature DB >> 17216704

Adalimumab-associated multiple sclerosis.

Lamiae Bensouda-Grimaldi, Denis Mulleman, Jean-Pierre Valat, Elisabeth Autret-Leca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17216704

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  20 in total

1.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

2.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

3.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

4.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 5.  New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.

Authors:  Takumi Matsumoto; Ichiro Nakamura; Ayumi Miura; Gen Momoyama; Katsumi Ito
Journal:  Clin Rheumatol       Date:  2012-11-14       Impact factor: 2.980

6.  Adalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case Report.

Authors:  Krista Kinard; Jessica A Walsh; Gopi K Penmetsa; Judith E A Warner
Journal:  Neuroophthalmology       Date:  2014-09-10

Review 7.  A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature.

Authors:  Yang-Seon Ryu; Sung-Hwan Park; Ji-Min Kim; Eun-Ji Kim; Jennifer Lee; Seung-Ki Kwok; Ji-Hyeon Ju; Ho-Youn Kim
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

Review 8.  Neuro-ophthalmic sarcoidosis.

Authors:  Robert P Baughman; Kenneth L Weiss; Karl C Golnik
Journal:  Eye Brain       Date:  2012-03-13

Review 9.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

10.  Psoriasis during interferon beta treatment for multiple sclerosis.

Authors:  Loredana La Mantia; F Capsoni
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.